Related Experiment Videos
[Demonstration of a bacterial structure in two human mediators: a sleep facilitating factor and a monokine]
Abstract:
A monoclonal anti-MDP antibody was found to bind to "Slow Wave Sleep" factor. This result confirms that this factor is a muramyl peptide and furthermore shows that it contains a structure characteristic of the synthetic adjuvant and of the bacterial cell wall, i.e. an acetylated muramic acid bound to L-alanine. This antibody was also shown to specifically inhibit a biological activity of a purified human monokine which induces fever. Because of these results and other recent observations we propose that a bacterial structure is present in certain mammalian mediators.
Insights
A novel antibody confirms that the Slow Wave Sleep factor is a bacterial muramyl peptide. This finding suggests bacterial structures may be present in mammalian fever-inducing mediators.
Area of Science:
- Immunology
- Neuroscience
- Microbiology
Context:
- The Sleep Wave Sleep factor's identity and function were previously unclear.
- Monoclonal antibodies offer precise tools for molecular identification.
Purpose:
- To identify the molecular nature of the Slow Wave Sleep factor.
- To investigate the role of bacterial structures in mammalian biological processes.
Summary:
- A monoclonal antibody against macrophage-depropanating peptide (MDP) binds to the Slow Wave Sleep factor.
- This binding confirms the factor is a muramyl peptide with a bacterial cell wall structure (acetylated muramic acid linked to L-alanine).
- The antibody also inhibits a fever-inducing human monokine, suggesting a link between bacterial components and mammalian mediators.
Impact:
- Identifies a specific bacterial peptide involved in sleep regulation.
- Provides evidence for the presence of bacterial structures in mammalian mediators.
- Opens new avenues for understanding sleep, fever, and potential microbial influences.